News

20 Budget-Friendly Ways To Gather Customer Insights
When I attend a presentation and someone in the crowd asks a question, I make it a point to seek them out afterwards and ask ...
Nasdaq17d
GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients - Nasdaq
ATLANTA, GA- June 10, 2025- GeoVax Labs, Inc., a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies against infectious diseases and solid tumors, today ...
Analytics Insight22d
Best Books to Read on Data Analytics
Beginners will find Data Analytics Made Easy a great way to start and build the basics. People with some experience, like business analysts, can read Storytelling with Data to get better at showing ...
Nasdaq22d
Metsera, Inc. to Present Clinical and Preclinical Data on MET-097i and Other Pipeline Assets at 85th American Diabetes Association Scientific Sessions - Nasdaq
Metsera will present preclinical data, including detailed pharmacokinetic and change in body weight data. Presentation Details: MET-097i: A fully biased ultra-long acting GLP-1 receptor agonist ...
PipelineReview.com24d
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC ...
Updated data on IBI363 monotherapy in patients with advanced NSCLC were reported (ClinicalTrials.gov, NCT05460767). As of the data cutoff date, April 7, 2025, a total of 136 patients with NSCLC had ...
Yahoo Finance25d
Incyte Announces Multiple Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted for Presentation at EHA 2025
WILMINGTON, Del., June 03, 2025--Multiple Incyte Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted at EHA 2025 ...
BioSpace25d
Incyte Announces Multiple Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted for Presentation at EHA ... - BioSpace
Late-breaking oral presentation will highlight new data from a trial of INCA033989, an anti-mutant calreticulin (mutCALR)-directed monoclonal antibody, in patients with essential thrombocythemia (ET) ...
Houston Chronicle27d
Qualitative & Quantitative Research Similarities - Chron.com
Qualitative research focuses on data that is expressed through words and actions. For example, showing a group of people a photo and asking how the photo makes them feel (happy, sad or mad) would ...
Houston Chronicle28d
Examples of Online Data Gathering Tools - Chron.com
Examples of Online Data Gathering Tools. The Internet is both an enormous collection of available information and a powerful resource for collecting new data.
Yahoo Finance29d
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - Yahoo Finance
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...
Mena FN29d
Adaptive Biotechnologies Highlights New Data At 2025 ASCO Annual Meeting And EHA 2025 Congress Demonstrating How Clonoseq® MRD Assessment Is Optimizing Patient ... - MENAFN.COM
Interim data from ADVANCE, a phase 2 randomized study of 306 transplant-eligible patients with NDMM shows the impact of MRD-guided assessments post-induction (ASCO Abstract 7503, June 3, 10:21-10: ...